Search clinical trials for: sarilumab SAR153191 (REGN88)
Total 192 results
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Canada, Denmark, Belgium, Japan, Korea, Republic of, Mexico, United States, Israel, Brazil, Australia, France, Germany, United Kingdom, Argentina, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation and more
-
Bristol-Myers SquibbCompleted
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
University Hospital Southampton NHS Foundation...Cancer Research UK; The Christie NHS Foundation Trust; Celldex Therapeutics; Oxford... and other collaboratorsActive, not recruitingB Cell LymphomaUnited Kingdom
-
Regeneron PharmaceuticalsRecruiting
-
Regeneron PharmaceuticalsSanofiCompletedEosinophilic EsophagitisUnited States, Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
Tufts Medical CenterNot yet recruiting
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaUnited States, Argentina, Belgium, Canada, France, Germany, Israel, Japan, Netherlands, South Africa
-
Regeneron PharmaceuticalsSanofiCompletedEosinophilic EsophagitisUnited States
-
Aetion, Inc.Active, not recruitingCOVID-19United States
-
Regeneron PharmaceuticalsSanofiCompleted
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompletedLeukemia | Chronic Lymphocytic Leukemia | Lymphocytic LeukemiaUnited States
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, Germany, Poland, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, New Zealand, Australia
-
SagaNaturaUniversidad Politecnica de MadridUnknown
-
Regeneron PharmaceuticalsSanofiCompletedHypersensitivity, Immediate | Dermatitis, Atopic | Moderate-to-Severe Atopic Dermatitis | Dermatitis, Dermatitis Atopic | Eczema, Skin Diseases, Skin | Diseases Genetic, Genetic | Diseases Inborn, Skin | Disease, Eczematous Skin | Hypersensitivity, Immune System DiseasesUnited States, Canada
-
Celldex TherapeuticsBristol-Myers SquibbCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Ovarian Carcinoma-Enrollment Completed | Colorectal Cancer (CRC)-Enrollment Completed | Renal Cell Carcinoma (RCC) (Phase ll Only) | Glioblastoma (GBM) (Phase ll Only)-Enrollment CompletedUnited States
-
PrECOG, LLC.Bristol-Myers SquibbCompleted
-
SanofiRegeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsSanofiCompletedStudy to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)Atopic Dermatitis (AD)United States, Canada
-
Innate PharmaCompletedAcute Myeloid LeukemiaFrance
-
Bristol-Myers SquibbCompleted
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, Poland, Belgium, Netherlands, Russian Federation, Ireland, United Kingdom, Slovakia, Austria, Spain
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, France, Poland, United Kingdom, Germany, Hong Kong, Canada, Korea, Republic of, Italy, Lithuania, Sweden
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Regeneron PharmaceuticalsSanofiTerminatedAtopic DermatitisUnited States, Korea, Republic of, Belgium, Czechia, Germany, Poland, Spain
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, Germany, Spain, Bulgaria, Japan, Canada, Denmark, Finland, Singapore, Estonia
-
Nicholas ButowskiNational Cancer Institute (NCI); Celldex TherapeuticsTerminatedGlioma | Malignant Glioma | Oligodendroglioma | Astrocytoma, Grade II | Glioma, Astrocytic | Oligoastrocytoma, MixedUnited States
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Mexico, United States, Hungary, Italy, Argentina, Australia, Brazil, Canada, Chile, Colombia, Lithuania, Poland, Romania, Russian Federation, South Africa, Turkey, Ukraine
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, Germany, Poland, Canada, Czechia, United Kingdom
-
Regeneron PharmaceuticalsSanofiActive, not recruitingBullous PemphigoidUnited States, Japan, Germany, Australia, France, Israel, Poland, Spain, Taiwan
-
Incyte CorporationTerminated
-
PfizerActive, not recruitingRheumatoid ArthritisUnited States
-
Regeneron PharmaceuticalsSanofiRecruitingEosinophilic Gastritis | Eosinophilic Duodenitis | Eosinophilic Gastrointestinal DiseaseUnited States, Japan, Poland, Italy, Australia
-
SanofiRegeneron PharmaceuticalsCompletedChronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)Belgium, Mexico, Turkey, Israel, Spain, Sweden, Argentina, Canada, Japan, United States, Australia, Chile, Portugal, Russian Federation
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Biphenotypic LeukemiaUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisUnited States, Italy, United Kingdom, Spain, Japan, Canada, Netherlands, New Zealand, Hungary, Czechia, Poland, Australia, Romania, Korea, Republic of
-
Celldex TherapeuticsTerminatedNeoplasms | Neoplasms by Histologic Type | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Clear-cell Metastatic Renal Cell CarcinomaUnited States
-
Craig L Slingluff, JrCelldex TherapeuticsCompleted
-
SanofiRegeneron PharmaceuticalsCompletedChronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)Italy, Ukraine, Hungary, United States, Bulgaria, Czechia, France, Germany, Netherlands, Poland, Romania, Russian Federation, United Kingdom
-
Regeneron PharmaceuticalsTerminated
-
Regeneron PharmaceuticalsCompletedHealthy | Chronic Stable IllnessUnited States
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
Regeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsTerminated
-
Regeneron PharmaceuticalsSanofiCompletedAllergic RhinitisUnited States, Canada
-
Regeneron PharmaceuticalsCompleted